Ha habido 50 transacciones internas recientes registradas para CymaBay Therapeutics, Inc. (CBAY), incluyendo 11 compras y 39 ventas. El total de compras internas fue valorado en $1.92M y el total de ventas internas en $21.25M.
Internos destacados con actividad reciente incluyen Wiggans Thomas G, Emster Kurt Von, Quinlan Paul T. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — CBAY
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2024-03-22 |
Wiggans Thomas G |
Director |
Devolución de Acciones |
14,010 |
$22.85 |
$320.13K |
- |
| 2024-03-22 |
Emster Kurt Von |
Director |
Devolución de Acciones |
14,010 |
$22.85 |
$320.13K |
- |
| 2024-03-22 |
Quinlan Paul T |
General Counsel |
Devolución de Acciones |
105,625 |
$22.85 |
$2.41M |
- |
| 2024-03-22 |
Dickinson Klara |
Chief Regulatory Officer |
Devolución de Acciones |
78,000 |
$22.85 |
$1.78M |
- |
| 2024-03-22 |
Loewy Caroline M |
Director |
Devolución de Acciones |
14,010 |
$22.85 |
$320.13K |
- |
| 2024-03-22 |
Shah Sujal |
Chief Executive Officer |
Devolución de Acciones |
357,500 |
$22.85 |
$8.17M |
- |
| 2024-03-22 |
Mcwherter Charles |
President of R&d |
Devolución de Acciones |
118,625 |
$22.85 |
$2.71M |
- |
| 2024-03-22 |
Lefebvre Eric |
Director |
Devolución de Acciones |
14,010 |
$22.85 |
$320.13K |
- |
| 2024-03-22 |
Wills Robert James |
Director |
Devolución de Acciones |
14,010 |
$22.85 |
$320.13K |
- |
| 2024-03-22 |
Dorling Janet |
Director |
Devolución de Acciones |
14,010 |
$22.85 |
$320.13K |
- |
| 2024-03-22 |
Shantharam Harish |
Chief Financial Officer |
Devolución de Acciones |
74,750 |
$22.85 |
$1.71M |
- |
| 2024-03-13 |
Quinlan Paul T |
General Counsel |
Ejercicio de Opciones (Venta) |
41,824 |
$7.89 |
$329.99K |
8,872 |
| 2024-03-13 |
Shah Sujal |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
14,625 |
$1.06 |
$15.5K |
- |
| 2024-02-12 |
Dorling Janet |
Director |
Venta Informativa |
6,000 |
$31.97 |
$191.85K |
- |
| 2024-01-24 |
Wiggans Thomas G |
Director |
Concesión de RSU |
14,010 |
$22.85 |
$320.13K |
14,010 |
| 2024-01-24 |
Emster Kurt Von |
Director |
Concesión de RSU |
14,010 |
$22.85 |
$320.13K |
14,010 |
| 2024-01-24 |
Quinlan Paul T |
General Counsel |
Concesión de RSU |
28,438 |
- |
- |
28,438 |
| 2024-01-24 |
Dickinson Klara |
Chief Regulatory Officer |
Concesión de RSU |
21,000 |
- |
- |
21,000 |
| 2024-01-24 |
Loewy Caroline M |
Director |
Concesión de RSU |
14,010 |
$22.85 |
$320.13K |
14,010 |
| 2024-01-24 |
Shah Sujal |
Chief Executive Officer |
Concesión de RSU |
96,250 |
- |
- |
267,551 |
| 2024-01-24 |
Mcwherter Charles |
President of R&d |
Concesión de RSU |
31,938 |
- |
- |
46,938 |
| 2024-01-24 |
Lefebvre Eric |
Director |
Concesión de RSU |
14,010 |
$22.85 |
$320.13K |
14,010 |
| 2024-01-24 |
Wills Robert James |
Director |
Concesión de RSU |
14,010 |
$22.85 |
$320.13K |
14,010 |
| 2024-01-24 |
Dorling Janet |
Director |
Concesión de RSU |
14,010 |
$22.85 |
$320.13K |
14,010 |
| 2024-01-24 |
Shantharam Harish |
Chief Financial Officer |
Concesión de RSU |
20,125 |
- |
- |
20,125 |
| 2024-01-19 |
Mcwherter Charles |
President of R&d |
Venta Informativa |
2,250 |
$23.67 |
$53.26K |
15,000 |
| 2024-01-16 |
Quinlan Paul T |
General Counsel |
Venta Informativa |
5,000 |
$23.58 |
$117.9K |
- |
| 2024-01-16 |
Menold Daniel |
Vice President, Finance |
Venta Informativa |
10,000 |
$23.58 |
$235.81K |
- |
| 2024-01-10 |
Dorling Janet |
Director |
Venta Informativa |
6,000 |
$23.86 |
$143.14K |
- |
| 2023-12-18 |
Mcwherter Charles |
President of R&d |
Ejercicio de Opciones (Venta) |
6,504 |
$5.00 |
$32.52K |
- |
| 2023-12-15 |
Quinlan Paul T |
General Counsel |
Venta Informativa |
5,000 |
$21.98 |
$109.9K |
- |
| 2023-12-15 |
Menold Daniel |
Vice President, Finance |
Venta Informativa |
10,000 |
$21.98 |
$219.85K |
- |
| 2023-12-11 |
Shah Sujal |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
12,973 |
$5.00 |
$64.87K |
- |
| 2023-12-11 |
Dorling Janet |
Director |
Venta Informativa |
6,000 |
$20.07 |
$120.42K |
- |
| 2023-11-17 |
Mcwherter Charles |
President of R&d |
Ejercicio de Opciones (Venta) |
236 |
$5.00 |
$1.18K |
234 |
| 2023-11-15 |
Quinlan Paul T |
General Counsel |
Venta Informativa |
5,000 |
$17.38 |
$86.89K |
- |
| 2023-11-15 |
Menold Daniel |
Vice President, Finance |
Venta Informativa |
- |
$17.38 |
- |
- |
| 2023-11-13 |
Shah Sujal |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
12,972 |
$5.00 |
$64.86K |
12,973 |
| 2023-11-10 |
Dorling Janet |
Director |
Venta Informativa |
7,000 |
$15.24 |
$106.7K |
- |
| 2023-10-18 |
Mcwherter Charles |
President of R&d |
Ejercicio de Opciones (Venta) |
10,401 |
$5.00 |
$52.01K |
- |
| 2023-10-16 |
Quinlan Paul T |
General Counsel |
Venta Informativa |
5,000 |
$13.76 |
$68.8K |
- |
| 2023-10-16 |
Menold Daniel |
Vice President, Finance |
Venta Informativa |
- |
$13.76 |
- |
- |
| 2023-10-09 |
Shah Sujal |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
12,972 |
$5.00 |
$64.86K |
25,945 |
| 2023-09-29 |
Emster Kurt Von |
Director |
Ejercicio de Opciones (Venta) |
5,249 |
$5.00 |
$26.25K |
- |
| 2023-09-18 |
Mcwherter Charles |
President of R&d |
Ejercicio de Opciones (Venta) |
236 |
$5.00 |
$1.18K |
706 |
| 2023-09-15 |
Quinlan Paul T |
General Counsel |
Venta Informativa |
24,000 |
$16.87 |
$404.92K |
- |
| 2023-09-15 |
Menold Daniel |
Vice President, Finance |
Ejercicio de Opciones (Venta) |
15,000 |
$1.72 |
$25.8K |
- |
| 2023-09-13 |
Avoro Capital Advisors Llc |
10 Percent Owner |
Venta Informativa |
250 |
$17.00 |
$4.25K |
250 |
| 2023-09-12 |
Avoro Capital Advisors Llc |
10 Percent Owner |
Venta Informativa |
300 |
$17.00 |
$5.1K |
300 |
| 2023-08-18 |
Mcwherter Charles |
President of R&d |
Ejercicio de Opciones (Venta) |
236 |
$5.00 |
$1.18K |
942 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
